In our practice, we consider all available treatment options, including GLP-1 agonists such as liraglutide and Semaglutide GLP-1
Chin HS, Chin DK, Morgenthaler NG, Vassart G, Costagliola S
En contraste, los agonistas de incretinas como GLP-1 y GIP, junto con agonistas de glucagn, representan una nueva generacin de frmacos con efectos ms especficos sobre la saciedad, el metabolismo lipdico y la homeostasis glucmica, y con un perfil de seguridad ms favorable
While GLP-1 drugs may offer neuroprotective effects relevant to glaucoma, the impact of dual-incretin therapies like tirzepatide on glaucoma remains unknown
Reduced Food Obsession : Life-changing reductions in cravings and food-related stress allow patients to focus on other life goals
In cases where inflammation is prominent, immunosuppressive therapies may be warranted to prevent further nerve damage and improve patient outcomes